Distribuzione geografica
Continente #
NA - Nord America 32.349
EU - Europa 2.257
AS - Asia 559
SA - Sud America 14
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 3
Totale 35.197
Nazione #
US - Stati Uniti d'America 32.325
DE - Germania 502
UA - Ucraina 425
IE - Irlanda 390
CN - Cina 355
IT - Italia 349
GB - Regno Unito 170
KR - Corea 93
FI - Finlandia 88
FR - Francia 80
SE - Svezia 79
RU - Federazione Russa 50
BE - Belgio 42
JP - Giappone 26
PL - Polonia 22
AT - Austria 20
NL - Olanda 16
CA - Canada 15
IN - India 15
SG - Singapore 15
HK - Hong Kong 8
TR - Turchia 8
UZ - Uzbekistan 8
VN - Vietnam 8
RO - Romania 7
AU - Australia 6
CL - Cile 6
EU - Europa 6
GR - Grecia 6
BR - Brasile 5
MX - Messico 5
DM - Dominica 4
ES - Italia 4
IR - Iran 4
ID - Indonesia 3
PT - Portogallo 3
BD - Bangladesh 2
CH - Svizzera 2
EG - Egitto 2
KG - Kirghizistan 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
QA - Qatar 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EE - Estonia 1
KW - Kuwait 1
LV - Lettonia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
Totale 35.197
Città #
Woodbridge 9.582
Wilmington 8.810
Houston 7.581
Fairfield 1.134
Ann Arbor 873
Chandler 616
Ashburn 582
Seattle 472
Cambridge 395
Jacksonville 377
Dublin 372
Medford 265
Dearborn 216
New York 153
Beijing 137
Lawrence 128
Rome 113
Colorado Springs 87
Zhengzhou 79
Mülheim 65
San Diego 65
Menlo Park 45
Brussels 42
Milan 38
Corona 34
London 27
Norwalk 25
University Park 23
Falls Church 19
Nanjing 17
Hefei 16
Kraków 16
Mountain View 16
Verona 15
Shanghai 14
Redwood City 13
Bologna 12
Kunming 12
Boardman 11
Washington 11
Palo Alto 10
Seoul 10
Chiswick 9
Creede 9
Vienna 9
Guangzhou 8
Hanoi 8
Naples 8
Nürnberg 8
Saint Petersburg 8
Chengdu 7
Groningen 7
Innsbruck 7
Kilburn 7
Nanchang 7
Redmond 7
Toronto 7
Hounslow 6
Jinan 6
Prescot 6
Chicago 5
Diyarbakır 5
Engelhard 5
Latina 5
Los Angeles 5
Santa Clara 5
Teramo 5
Auburn Hills 4
Baotou 4
Birmingham 4
Fuzhou 4
Montreal 4
Mumbai 4
Phoenix 4
Pont-Canavese 4
Rieti 4
Roseau 4
San Mateo 4
Turin 4
Amsterdam 3
Athens 3
Bucharest 3
Chennai 3
Chongqing 3
Frankfurt am Main 3
Hanover 3
Hebei 3
Helsinki 3
Islington 3
Izmir 3
Lappeenranta 3
New Bedfont 3
Philadelphia 3
Saint Paul 3
San Francisco 3
Shaoxing 3
São Paulo 3
Tokyo 3
Trieste 3
Ypsilanti 3
Totale 32.808
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 537
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 454
Acute foetal distress and umbilical cord blood banking 434
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 427
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 424
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 424
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 421
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 417
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 415
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 411
null 410
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 410
Pure erythroid leukemia in advanced breast cancer. 408
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 404
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 402
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 401
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 400
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 400
Management of hematological malignancies in patients affected by renal failure 400
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 398
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 398
Cold autoimmune hemolytic anemia resolved by rituximab 397
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 395
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 393
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 393
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 392
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 390
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 388
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 387
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 386
Cutaneous involvement in multiple myeloma and bortezomib 386
null 385
Bortezomib-related colon mucositis in a multiple myeloma patient 384
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 384
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 383
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 381
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 376
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). 375
Evaluation of biological features of cord blood units collected with different methods after cesarean section 374
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 372
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 372
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 371
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 370
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 367
Home care management of patients affected by hematologic malignancies: A review 364
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 364
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 362
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 362
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 361
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 361
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 360
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 356
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 356
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 355
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 355
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 355
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 354
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 351
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 349
Opioids in pain management of blood-related malignancies 348
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 348
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 347
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 347
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 346
Sleep complaints in hospitalized Italian patients with hematological malignancies 345
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 338
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 337
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 333
Stem cell mobilization after coronary artery bypass grafting. 332
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 325
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 320
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 319
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 319
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 318
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 316
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 315
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 308
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 305
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 304
Pain management in multiple myeloma. 290
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 283
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 280
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 270
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 260
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 254
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 253
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 218
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 181
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 153
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 146
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 145
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 138
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 136
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 133
Bone marrow aspiration and biopsy-related pain management 127
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 126
Management of pregnant chronic myeloid leukemia patients 123
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 120
Totale 33.616
Categoria #
all - tutte 69.736
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.736

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.849 0 0 0 0 0 0 0 536 700 793 924 896
2019/20209.440 714 699 630 822 744 979 790 769 985 854 724 730
2020/20216.244 671 727 700 771 623 706 742 660 144 197 232 71
2021/20221.280 61 170 54 52 45 113 76 76 70 103 80 380
2022/20231.991 184 144 60 184 124 370 173 95 143 346 124 44
2023/2024680 101 33 81 44 125 219 31 46 0 0 0 0
Totale 35.632